Skip to content

Pediatrix Medical Group MD Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

ARD
Ardent Health PartnersARDT
ICU Medical logo
ICU MedicalICUI

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×
P/S+0.3×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's preferred stock, shares authorized?
Pediatrix Medical Group (MD) reported preferred stock, shares authorized of $1M in Q1 2026.
How has Pediatrix Medical Group's preferred stock, shares authorized changed year-over-year?
Pediatrix Medical Group's preferred stock, shares authorized decreased by 99.9% year-over-year, from $1B to $1M.
What is the long-term trend for Pediatrix Medical Group's preferred stock, shares authorized?
Over 5 years (2020 to 2025), Pediatrix Medical Group's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $1M to $1M.